As investors hunt for the next big opportunity, grey market premiums (GMP) serve as a crucial barometer of market sentiment. Today, on December 2, 2025, the IPO landscape buzzes with activity. Revelcare IPO, already in its second subscription day, commands a robust 50% GMP, signaling strong listing gains ahead.
Meanwhile, Meesho IPO, the e-commerce giant’s highly anticipated debut, trades at a 42% premium in the grey market, while Vidya Wires IPO gears up with a steady 12% GMP. These figures reflect investor confidence amid a resilient economy and booming sectors like beauty, digital commerce, and manufacturing.
This comprehensive guide dives deep into the latest IPO GMP today for these marquee issues. We explore subscription statuses, key timelines, investment requirements, and strategic insights to help you navigate these opportunities. Whether you’re a seasoned trader eyeing short-term flips or a long-term investor betting on growth stories, understanding GMP trends empowers smarter decisions. Stay tuned as we unpack the numbers, risks, and rewards shaping December’s IPO rush.
Understanding Grey Market Premium (GMP) in Today’s IPO Market
Grey market premium, or GMP, captures the unofficial trading buzz before an IPO lists on exchanges. It represents the extra amount investors pay above the issue price for shares in the unlisted market, hinting at potential listing pops. On December 2, 2025, GMPs across the board point to optimism. Revelcare’s GMP hit ₹65 on a ₹130 upper band, translating to a 50% premium and an estimated listing price of ₹195. Meesho’s ₹46.5 GMP on ₹111 yields a 42% surge, eyeing ₹157.5 at debut. Vidya Wires, at ₹6 GMP over ₹52, shows a modest 12% edge, projecting ₹58.
Investors closely monitor these metrics because they correlate with subscription fervor. High GMPs often precede oversubscribed issues, as seen in Revelcare’s 51x Day 2 tally. However, GMP isn’t foolproof—market volatility, economic shifts, or regulatory tweaks can sway outcomes. Experts advise blending GMP data with fundamentals: revenue growth, sector tailwinds, and peer valuations. In 2025’s IPO boom, where mainboard and SME offerings raised over ₹1 lakh crore year-to-date, GMPs have averaged 25-30% gains, rewarding early birds.
For retail investors, GMP signals entry points. A rising premium like Meesho’s (up from ₹33 last week) screams demand, while Vidya Wires’ stability suits conservative plays. Always cross-check with official sources like BSE or NSE, as grey market trades carry risks like non-delivery. As we gear up for December’s listings, these premiums underscore a market hungry for innovation-driven stocks.
Revelcare IPO GMP Today: 50% Premium Signals Blockbuster Listing
Revelcare IPO captivates the SME segment with its digital-first approach to beauty and personal care. Launched on December 1, 2025, this ₹24.10 crore fresh issue targets health-conscious millennials through innovative scalp care and anti-dandruff solutions. On Day 2 today, December 2, the IPO’s GMP stands at an impressive ₹65, a 50% premium over the ₹130 upper price band. This translates to an expected listing price of ₹195, promising up to ₹6,500 gains per lot (two lots of 2,000 shares at ₹26,000 investment).
Subscription status underscores the hype: by 3 PM today, Revelcare achieved 51x overall oversubscription. Retail investors led with 70x, followed by Non-Institutional Investors (NII) at 105x (small NII 95x, big NII 110x), and Qualified Institutional Buyers (QIB) at 7x. This surge from Day 1’s 6-7x reflects broadening appeal, fueled by the company’s ₹14.4 crore six-month revenue and ₹3.2 crore PAT as of September 2025.
Revelcare, a book-built issue entirely of fresh shares, allocates 50% to QIBs, 35% to retail, and 15% to NIIs, with market makers securing ₹1.22 crore. The price band of ₹123-₹130 (face value ₹10) requires a minimum ₹26,000 for two lots—ideal for retail participation. Key dates include closure on December 3, allotment on December 4, refunds/crediting on December 5, and BSE SME listing on December 8.
What drives this GMP spike? Revelcare’s niche in targeted treatments—like hair growth serums and flaking-control ampoules—taps a ₹50,000 crore Indian BPC market growing at 15% CAGR. With 25 professionals and exports to key regions, the firm positions for scalability. Analysts project 40-50% listing gains, but warn of SME volatility. For risk-averse investors, the GMP’s climb from ₹16 (pre-open) to ₹65 signals momentum—apply at cut-off for maximum allotment chances. Revelcare exemplifies how focused innovation turns small IPOs into wealth creators.
Meesho IPO GMP Today: E-Commerce Powerhouse Eyes 42% Listing Pop
Meesho IPO dominates headlines as SoftBank-backed e-commerce titan storms the mainboard. Set to open December 3, 2025, this ₹5,421 crore behemoth blends ₹4,250 crore fresh issue with ₹1,171 crore offer-for-sale (OFS), diluting promoter stakes. Today’s GMP of ₹46.5 (42% over ₹111 upper band) forecasts a ₹157.5 listing price, potentially yielding ₹6,700 per lot (135 shares at ₹14,985).
Pre-subscription buzz is electric, with GMP up 40% from ₹33 last week. Meesho’s model—zero-commission, value-driven shopping—boasts 213 million active users and 575,000 sellers, ranking it India’s top e-commerce platform by orders (183 crore in FY25). Revenue hit ₹7,600 crore in FY25, with losses narrowing to ₹700 crore (H1 FY26), thanks to AI investments and Valmo logistics handling one-third of national shipments.
The price band of ₹105-₹111 (face value ₹1) mandates 135 shares per lot, requiring ₹14,985 for retail, ₹29,790 for small NII (two lots), and ₹1,39,920 for big NII (10 lots). Allocation: 50% QIB, 35% retail, 15% NII. Timeline: Opens December 3-5, allotment December 8, refunds/crediting December 9, BSE/NSE listing December 10.
Meesho’s GMP reflects sector tailwinds: India’s e-commerce market swells to $350 billion by 2030, with Meesho’s 39,000 content creators driving ₹946 crore NMV. Peers like Nykaa trade at 8x sales; Meesho’s 7x valuation looks attractive for growth chasers. Risks include competition from Amazon and Flipkart, plus ongoing losses from marketing spends. Yet, with 2,000 employees and pan-India logistics, Meesho promises multibagger potential. Retail investors: Bid early for the hype—GMP trends suggest 35-45% gains, but diversify amid valuation debates.
Vidya Wires IPO GMP Today: Steady 12% Premium for Manufacturing Bet
Vidya Wires IPO rounds out today’s spotlight, a mainboard play in copper-aluminum wires for power and mobility. Opening December 3, 2025, the ₹300 crore issue comprises ₹274 crore fresh and ₹26 crore OFS. GMP today at ₹6 (12% over ₹52 upper band) eyes a ₹58 listing, offering ₹1,800 per lot (288 shares at ₹14,976).
As Gujarat’s fourth-largest player (5.7% market share), Vidya Wires exports to 18 countries, serving renewables and railways. FY25 revenue rose 25% to ₹450 crore, PAT up 59% to ₹45 crore, with 139 employees fueling efficiency. GMP’s stability—from ₹5 low to ₹10 high—mirrors conservative demand in industrials.
Price band ₹48-₹52 (face value ₹1) requires 288 shares minimum, ₹14,976 retail, ₹29,664 small NII, ₹1,39,920 big NII. Allocation: 50% QIB, 35% retail, 15% NII. Dates: December 3-5 open, December 8 allotment, December 9 refunds/crediting, BSE/NSE list December 10.
This GMP signals 10-15% gains, appealing to value investors. Vidya’s ports access (Hazira, Mundra) and clean energy focus align with India’s $500 billion infra push. Peers like Polycab trade at 15x earnings; Vidya’s 12x invites entry. Watch for subscription spikes—anchor bids today could lift GMP. For long-haul, it’s a defensive pick amid global supply chains.
Comparing Today’s IPO GMP: Revelcare vs Meesho vs Vidya Wires
| Parameter | Revelcare IPO | Meesho IPO | Vidya Wires IPO |
|---|---|---|---|
| Issue Size | ₹24.10 Cr (Fresh) | ₹5,421 Cr (Fresh + OFS) | ₹300 Cr (Fresh + OFS) |
| Price Band | ₹123-130 | ₹105-111 | ₹48-52 |
| Lot Size | 2 lots (2,000 shares) | 135 shares | 288 shares |
| Min Investment | ₹26,000 | ₹14,985 | ₹14,976 |
| GMP Today (Dec 2) | ₹65 (50%) | ₹46.5 (42%) | ₹6 (12%) |
| Est. Listing Price | ₹195 | ₹157.5 | ₹58 |
| Subscription (Latest) | 51x (Day 2) | Pre-open buzz | Pre-open |
| Listing Date | Dec 8 (BSE SME) | Dec 10 (BSE/NSE) | Dec 10 (BSE/NSE) |
| Sector Focus | Beauty & Personal Care | E-Commerce | Wires & Conductors |
This table highlights contrasts: Revelcare’s SME agility yields highest GMP percentage, Meesho’s scale drives absolute premiums, and Vidya’s industrials offer stability. Choose based on risk appetite—SME for flips, mainboard for anchors.
How to Apply for These IPOs: Step-by-Step Guide for Retail Investors
Applying for IPOs like Revelcare, Meesho, or Vidya Wires is straightforward via ASBA or UPI. First, ensure your demat account links to a bank. Log into your broker’s app (Zerodha, Groww) or bank portal. Select the IPO, enter bid details (lot size, price—prefer cut-off), and confirm UPI mandate. For Meesho, aim for multiple applications across family accounts to boost allotment odds.
Retail quota caps at 35%, so oversubscription dilutes shares—use lottery method wisely. Track status on registrar sites (Kfin for Revelcare/Meesho, MUFG for Vidya). Post-allotment, monitor GMP for sauda opportunities, but avoid overexposure. In 2025’s retail surge, platforms processed 10 crore bids; time yours pre-noon for smooth execution.
Risks and Strategies: Navigating GMP Volatility in 2025 IPOs
GMPs tantalize, but 2025’s market—up 15% YTD—hides pitfalls. Revelcare’s SME status risks liquidity crunches post-listing, while Meesho’s losses (₹700 Cr H1) invite valuation corrections. Vidya Wires faces commodity swings. Mitigate with diversification: Allocate 5-10% portfolio to IPOs.
Strategies: For GMP chasers, enter at 20%+ premiums; long-termers eye fundamentals like Meesho’s 183 Cr orders. Use tools like Chittorgarh for live updates. Remember, SEBI’s “when-listed” platform curbs grey excesses—focus on regulated plays.
Future Outlook: December 2025 IPO Pipeline and Market Trends
December 2025 promises more: Aequs (GMP ₹44.5, 36%) joins the fray on December 3. With Nifty at 25,000, IPOs tap $100 Bn fundraising. Sectors like e-commerce (20% CAGR) and renewables shine. Investors: Subscribe selectively, track GMP daily via BSE.
In conclusion, today’s IPO GMP—Revelcare’s 50%, Meesho’s 42%, Vidya’s 12%—heralds a vibrant month. Arm yourself with data, apply judiciously, and let market wisdom guide your moves. Happy investing!
